
Mark M. Tungesvik, MD
Hematology/oncology in Columbia, MO
- Enrolled in Medicare
- Accepts Medicare assignment
- 25 years since graduation
- Public record — not managed by the clinician
About Dr. Mark Tungesvik
Dr. Mark Tungesvik is a physician specializing in hematology/oncology practicing in Columbia, MO, a graduate of University of Missouri, Columbia School of Medicine (2001). Affiliated with Boone Hospital Center, Fitzgibbon Hospital. Treated 926 Medicare patients in 2024.
- Hematology/oncology
- Accepts Medicare assignment
- In-person visits at the practice
Provider details
| Specialty | Hematology/oncologyOther hematology/oncology doctors in Columbia |
|---|---|
| Credentials | MD |
| Education | University of Missouri, Columbia School of Medicine, 2001CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1497723472National Provider Identifier (CMS NPPES), issued March 2006 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Dr. Mark Tungesvik's specialties and state licenses
- Hematology & Oncology Primary
License: MO 2005004970
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Where Dr. Mark Tungesvik practices
-
Practice address 1705 E Broadway, Suite 100, Columbia, MO 65201 Directions
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Hospital affiliations of Dr. Mark Tungesvik
- Boone Hospital CenterHospital · Columbia, MO
- Fitzgibbon HospitalHospital · Marshall, MO
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Mark Tungesvik's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as subgroup. Source: CMS Care Compare, PY 2024 clinician public reporting.
Dr. Mark Tungesvik's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 544 | $116.73 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 437 | $15.36 |
| Administration of chemotherapy into vein, 1 hour or less | 378 | $109.71 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 335 | $82.93 |
| Injection of additional new drug or substance into vein | 321 | $13.34 |
| Injection of drug or substance under skin or into muscle | 245 | $12.83 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 183 | $24.42 |
| Ct scan of chest with contrast | 118 | $106.10 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Dr. Mark Tungesvik (2025)
$2,946.23 in 138 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 130 | $2,441.73 |
| Education | 8 | $504.50 |
Paying companies: AbbVie Inc. ($308.89), Daiichi Sankyo Inc. ($301.37), E.R. Squibb & Sons, L.L.C. ($285.75), Pfizer Inc. ($208.90), NOVARTIS PHARMACEUTICALS CORPORATION ($197.59), Merck Sharp & Dohme LLC ($186.17).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Mark Tungesvik
What kind of clinician is Dr. Mark Tungesvik?
Dr. Mark Tungesvik is listed as a physician specializing in hematology/oncology.
Where does Dr. Mark Tungesvik practice?
The main practice address at 1705 E Broadway, Suite 100, Columbia, MO 65201.
What is the NPI number of Dr. Mark Tungesvik?
The National Provider Identifier is 1497723472.
Does Dr. Mark Tungesvik accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Mark Tungesvik affiliated with?
Boone Hospital Center, Fitzgibbon Hospital.
Where did Dr. Mark Tungesvik go to medical school?
University of Missouri, Columbia School of Medicine, graduating in 2001.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2026-07-28 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.